Nectar Lifescience Ltd Share Price
(NECLIFE)
₹28.84
as on 04:02PM, 21 Feb 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -25.32 % |
3 Month Return | -12.69 % |
1 Year Return | -27.97 % |
Market Stats | |
Previous Close | ₹29.93 |
Open | ₹29.76 |
Volume | 7.98L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹671.21Cr |
P/E Ratio
39.38
PEG Ratio
98.45
Market Cap
₹671.21 Cr
P/B Ratio
0.63
EPS
0.22
Dividend Yield
0Sector
Pharmaceuticals
ROE
0.47
Key events for Nectar Lifescience Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 32.54% to 54.72% in Dec 2024 quarter
Revenue Rich
Revenue is up for the last 3 quarters, 359.85 Cr → 455.56 Cr (in ₹), with an average increase of 11.0% per quarter
Promoter Holding Up
Promoters have increased holdings from 44.35% to 44.53% in Dec 2024 quarter
Profit Spike
Netprofit is up for the last 4 quarters, 0.59 Cr → 7.84 Cr (in ₹), with an average increase of 51.9% per quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.2% return, outperforming this stock by 130.2%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 63.8% return, outperforming this stock by 91.8%
FII Holding Down
Foreign Institutions have decreased holdings from 2.57% to 0.73% in Dec 2024 quarter
Price Dip
In the last 1 month, NECLIFE stock has moved down by -25.3%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.53% | 0.40 | |
Foreign Institutions | 0.73% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 54.72% | 68.14 | |
Others | 0.02% |
Nectar Lifescience Ltd in the last 5 years
Lowest (-284.58x)
December 21, 2023
Today (39.38x)
February 20, 2025
Industry (51.76x)
February 20, 2025
Highest (403.33x)
August 26, 2020
Nectar Lifescience Ltd’s net profit jumped 399.36% since last year same period to ₹7.84Cr in the Q3 2024-2025. On a quarterly growth basis, Nectar Lifescience Ltd has generated 40% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.17%.
Read More about DividendsBearish
Neutral
Bullish
Nectar Lifescience Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹671.21 Cr | 28.67% | 0.69 | ₹5 Cr | ₹1,684 Cr | |
NA | ₹28.18 Cr | -5.82% | 0.62 | NA | NA | |
BUY | ₹15,787.43 Cr | 23.59% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹172.50 Cr | 297.04% | 0.62 | -₹25 Cr | ₹42 Cr | |
BUY | ₹14,641.85 Cr | 502.36% | 0.54 | ₹300 Cr | ₹1,558 Cr |
Organisation | Nectar Lifescience Ltd |
Headquarters | Chandigarh |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Nectar Lifescience Ltd share price today stands at ₹28.84, Open: ₹29.76, Previous Close: ₹29.93, High: ₹30.74, Low: ₹28.5, 52 Week High: ₹56.5, 52 Week Low: ₹26.15.
Nectar Lifescience Ltd is listed on NSE
Nectar Lifescience Ltd is listed on BSE
Today's traded volume of Nectar Lifescience Ltd(NECLIFE) is 7.98L.
Today's market capitalisation of Nectar Lifescience Ltd(NECLIFE) is ₹671.21Cr.
Nectar Lifescience Ltd (NECLIFE) share price is ₹28.84. It is down -48.96% from its 52 Week High price of ₹56.5
Nectar Lifescience Ltd (NECLIFE) share price is ₹28.84. It is up 10.29% from its 52 Week Low price of ₹26.15
PE Ratio of Nectar Lifescience Ltd is 39.38
PE ratio = Nectar Lifescience Ltd Market price per share / Nectar Lifescience Ltd Earnings per share